Rivernorth Capital Management’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Rivernorth Capital Management’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-49,499	Closed	-$1.49K	–	577
2023 Q3	$1.49K	Hold	49,499	–	–	﹤0.01%	514
2023 Q2	$1.49K	Hold	49,499	–	–	﹤0.01%	543
2023 Q1	$3.46K	Hold	49,499	–	–	﹤0.01%	561
2022 Q4	$1.49K	Hold	49,499	–	–	﹤0.01%	671
2022 Q3	$11K	Sell	49,499 -500	-1%	-$123	﹤0.01%	674
2022 Q2	$5K	Hold	49,999	–	–	﹤0.01%	725
2022 Q1	$22K	Hold	49,999	–	–	﹤0.01%	673
2021 Q4	$20K	Hold	49,999	–	–	﹤0.01%	660
2021 Q3	$33K	Hold	49,999	–	–	﹤0.01%	487
2021 Q2	$76K	Hold	49,999	–	–	﹤0.01%	421
2021 Q1	$84K	Buy	+49,999	New	+$101K	0.01%	381

Rivernorth Capital Management's APGNW Position: Q4 2023 in Review

Rivernorth Capital Management sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q4 2023, closing a stake of 49,499 shares — an estimated $1.49K sold.

Rivernorth Capital Management first reported a position in APGNW in Q1 2021 and held it in 11 quarters. The position peaked at $84K in Q1 2021. 0 funds tracked by Wall St. Rank hold APGNW as of Q4 2023.

Rivernorth Capital Management reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q4 2023 after selling out during the quarter.
Rivernorth Capital Management sold 49,499 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q4 2023, an estimated $1.49K.
Rivernorth Capital Management first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 11 quarters.
Rivernorth Capital Management's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $84K in Q1 2021.
0 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q4 2023.

Based on Rivernorth Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.